Flexner C - Search Results

1

Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis.

Flexner C, Thomas DL, Swindells S. Flexner C, et al. Curr Opin HIV AIDS. 2019 Jan;14(1):13-20. doi: 10.1097/COH.0000000000000510. Curr Opin HIV AIDS. 2019. PMID: 30394948 Review.

2

Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.

Swindells S, Siccardi M, Barrett SE, Olsen DB, Grobler JA, Podany AT, Nuermberger E, Kim P, Barry CE, Owen A, Hazuda D, Flexner C. Swindells S, et al. Among authors: flexner c. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):125-132. doi: 10.5588/ijtld.17.0486. Int J Tuberc Lung Dis. 2018. PMID: 29506608 Free PMC article.

3

Interest of Youth Living With HIV in Long-Acting Antiretrovirals.

Weld ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, Ryscavage P, Gaur AH, Chakraborty R, Swindells S, Flexner C, Agwu AL. Weld ED, et al. Among authors: flexner c. J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):190-197. doi: 10.1097/QAI.0000000000001896. J Acquir Immune Defic Syndr. 2019. PMID: 30418298 Free PMC article.

4

Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV.

Bollinger RC, Thio CL, Sulkowski MS, McKenzie-White J, Thomas DL, Flexner C. Bollinger RC, et al. Among authors: flexner c. Lancet HIV. 2020 Jun;7(6):e443-e448. doi: 10.1016/S2352-3018(19)30342-X. Epub 2019 Dec 20. Lancet HIV. 2020. PMID: 31870675 Free PMC article. Review.

5

Long-acting drugs and formulations for the treatment and prevention of HIV infection.

Flexner C, Owen A, Siccardi M, Swindells S. Flexner C, et al. Int J Antimicrob Agents. 2021 Jan;57(1):106220. doi: 10.1016/j.ijantimicag.2020.106220. Epub 2020 Nov 6. Int J Antimicrob Agents. 2021. PMID: 33166693 Free PMC article. Review.

6

Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.

Weld ED, Astemborski J, Kirk GD, Sulkowski MS, Katz S, Rothman R, Solomon SS, Matthews GV, Hsieh YH, Verma M, Traverso G, Swindells S, Owen A, Feld J, Flexner C, Mehta SH, Thomas DL. Weld ED, et al. Among authors: flexner c. Clin Infect Dis. 2022 Aug 24;75(1):3-10. doi: 10.1093/cid/ciab913. Clin Infect Dis. 2022. PMID: 34699587 Free PMC article.

7

Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.

Rajoli RKR, Podany AT, Moss DM, Swindells S, Flexner C, Owen A, Siccardi M. Rajoli RKR, et al. Among authors: flexner c. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):937-944. doi: 10.5588/ijtld.17.0515. Int J Tuberc Lung Dis. 2018. PMID: 29991405 Free PMC article.

8

Antiretroviral implants for treatment and prevention of HIV infection.

Flexner C. Flexner C. Curr Opin HIV AIDS. 2018 Jul;13(4):374-380. doi: 10.1097/COH.0000000000000470. Curr Opin HIV AIDS. 2018. PMID: 29794816 Review.

9

Long-acting implants to treat and prevent HIV infection.

Weld ED, Flexner C. Weld ED, et al. Among authors: flexner c. Curr Opin HIV AIDS. 2020 Jan;15(1):33-41. doi: 10.1097/COH.0000000000000591. Curr Opin HIV AIDS. 2020. PMID: 31764198 Free PMC article.

10

The critical need for alternative antiretroviral formulations, and obstacles to their development.

Swindells S, Flexner C, Fletcher CV, Jacobson JM. Swindells S, et al. Among authors: flexner c. J Infect Dis. 2011 Sep 1;204(5):669-74. doi: 10.1093/infdis/jir370. Epub 2011 Jul 25. J Infect Dis. 2011. PMID: 21788451 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters